Stem Cell Therapies for AMD Making Strides

Stem Cell Therapies for AMD Making Strides - Eye On Innovation Article - OIS

In 2013, the first clinical study of stem cells in ophthalmology set high hopes that companies may one day develop cell-based therapies for neovascular age-related macular degeneration (AMD). A recent spate of clinical and intellectual advances certainly hasn’t dampened anyone’s enthusiasm. Research scientists continue to focus on replacement therapy for the retinal pigment epithelium (RPE)…

Read More

Avedro’s Long Wait for FDA Approval is Over

Avedro’s Long Wait for FDA Approval Is Over - OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 082″] The FDA approved Avedro’s New Drug Application for its riboflavin ophthalmic solution/KXL System (corneal cross-linking for the treatment of keratoconus and corneal ectasia following refractive surgery). OIS Co-chair Gil Kliman, an investor in Avedro, lays out the company’s next plans. 10 Top Topics in this OIS Podcast: Can you give…

Read More

Muller Explains Departure from Avedro; Opportunity in New Venture

OIS-Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 071″] David Muller came close to writing the final chapter of Avedro’s push to have corneal cross-linking approved by the FDA. But he opted to leave the company before the final approval came through to pursue a new venture called Allotex. In this interview with OIS Podcast, Muller explains his decision…

Read More

Ocata Therapeutics

Ocata Therapeutics, which has trademarked the term Regenerative Ophthalmology, is developing stem cell therapies for Stargardt macular degeneration, dry age-related macular degeneration (AMD), and myopic macular degeneration, Chief Medical Officer Eddy Anglade, MD, reported at OIS@AAO. The company’s intellectual property portfolio includes pluripotent stem cell platforms – hESC and induced pluripotent stem cell (iPSC) –…

Read More

Muller On The FDA, PIXL And Dairy Farms

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 063″] Avedro CEO David Muller updates us on Avedro’s securing FDA approval for its KXL System. He also tells us what he learned on his dairy farm in Vermont. Podcast Description for Web: Avedro’s long saga with the FDA continues. Last week, the firm resubmitted the NDA for its riboflavin ophthalmic…

Read More

Precision Medicine Gets a Boost & Ophthalmology is Ready

Precision medicine got a boost in mid-September when National Institutes of Health (NIH) advisory committee released a framework for building a cohort of 1 million or more Americans that researchers can draw on for data and specimens, an endeavor in which ophthalmology is well positioned to play an important role, according to one prominent ophthalmology…

Read More

Avedro CEO Muller Answers Questions About The FDA’s Questions

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 039″] David Muller, CEO of Avedro, addresses delays in the FDA’s review of the company’s riboflavin ophthalmic solution/KXL System for corneal cross-linking and discusses the considerable potential of PIXL. Podcast Guest David Muller, PhD Dr. Muller recognized the potential of using advanced methods to gently reshape the cornea and in 2007…

Read More

Talley Rostov Works To Improve Global Vision

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 030″] Seattle Ophthalmologist Audrey Talley Rostov explains how she became involved in an international movement to end corneal blindness.

Read More

Hear How Avedro’s Muller Is Building A Cross-Linking Powerhouse

OIS Podcast

Episode 007 CEO David Muller, maps out Avedro’s designs to dominate the corneal cross-linking market and potentially change the game of vision correction. Podcast Guest David Muller, PhD Dr. Muller recognized the potential of using advanced methods to gently reshape the cornea and in 2007 founded Avedro, Inc., where he serves as the CEO. Under…

Read More

CXLO

Presenter: Roy Rubinfeld, MD Dr. Rubinfeld was the first Washington area ophthalmologist to become involved in the care of laser vision correction patients in 1991. He has performed tens of thousands of LASIK and many PRK and other vision correction procedures. View Full Profile

Read More

Cross Linking Market Overview

Presenter: Stephen Slade, MD Stephen Glenn Slade graduated from the University of Texas (Summa Cum Laude, Phi Beta Kappa) with a final, elective year spent at Guy’s Hospital in London. He completed a residency at LSU in New Orleans and fellowships at Baylor College of Medicine and Project ORBIS in New York. View Full Profile

Read More

Cross Linking – Panel Discussion

Moderators: Stephen Slade, MD Stephen Glenn Slade graduated from the University of Texas (Summa Cum Laude, Phi Beta Kappa) with a final, elective year spent at Guy’s Hospital in London. He completed a residency at LSU in New Orleans and fellowships at Baylor College of Medicine and Project ORBIS in New York. View Full Profile…

Read More